Can Wearable Technology be Used to Predict Exercise Intensity

NCT ID: NCT06871943

Last Updated: 2025-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a knowledge gap in the literature around using watts to measure exercise intensity in walking and running, this is largely due to new technological developments. Whereas the relationship is widely recognised and used for cycling in elite to clinical populations.

While the relationship breathing rate and exercise intensity is well established, this are no guidelines using breathing rate as a physiological measure of intensity. New technology may aid to bridge these gaps.

The main aims of the study are: -

Can the relationship between oxygen uptake and watts during incremental exercise Can breathing frequency be used to determine aerobic exercise intensity

The participants will complete two 9 minute incremental accredited exercise tests on the flat around cones and on treadmill at the given speed of walking around the cones. The test will stop at 6.8kph or at participant volition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The experimental feasibility study involves testing if the wearable technology (Stryd accelerometer) can translate work rate into an accurate measurement of watts (energy produced) within cardiac populations, when compared to V̇o2 consumed. While also testing to see the measured relationship between breathing rate and exercise induced exertion levels. The testing will involve participants working to a sub maximal incremental shuttle walk test pace on treadmill (unto 6.8kph) and following standard procedure on the flat around cones. They will be wearing a Stryd accelerometer attached to their training shoes and Respa breathing monitor attached to their lapel or t-shirt. V̇o2 will be measured using a Cortex Metalyzer 3B. All participants will perform the testing twice in a counter balanced order (i.e participant one will perform the treadmill first, while the next will perform the testing on the flat around cones).

Participants will be recruited from the cardiac rehabilitation team at the University Hospital of the North Midlands.

The pace of the treadmill will be in line with the constant walking pace required to achieve a steady state at each level of the incremental shuttle walk test protocol. The treadmill will not be an incline as normal testing is on flat surface. The Stryd and Respa will be linked to a mobile device where watts and breathing frequency readings will be gathered, progression to the next stage will be at one minute.

Each test lasts for 9 minutes, with a 15-minute recovery period between tests and pre and post exercise tests, participation will take approximately 1 hour. Post testing the participant can remove the device and face mask; while being encouraged to cool down until heart rate is within 20 beats of resting levels but they can leave at any time.

Power will be measured in watts from the Stryd accelerometer, V̇O2 will be measured in ml.kg.min, while respiratory rate will be breaths per minute To remove anomalies from the excel sheet, the watts and breathing frequency readings will be taken from smoothing the data within the last 30 seconds of the level. This will allow the participant to adjust to the change in pace and achieve a steady state of walking. The V̇o2 reading will also be taken in the last 30 seconds with the average of the smoothed data used.

It is anticipated that all participants will not finish the testing up to stage 9, due to volitional fatigue. All data will be reported and recorded, with a n value for each stage, denoting the power and the perceived drop out at each point.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction (MI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Myocardial Infraction

Participants who have suffered a myocardial infraction in the past 6 months and are actively enrolled onto a cardiac rehabilitation programme

Incremental Shuttle Walk Tests

Intervention Type OTHER

The participants will walk on the flat around cones placed 9 meters apart inline with the procedure for the incremental shuttle walk test. They will also walk at a matched speed to the incremental shuttle walk test on a treadmill. This will be performed in a counter balanced procedure to reduce any benefit of a learning effect.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Incremental Shuttle Walk Tests

The participants will walk on the flat around cones placed 9 meters apart inline with the procedure for the incremental shuttle walk test. They will also walk at a matched speed to the incremental shuttle walk test on a treadmill. This will be performed in a counter balanced procedure to reduce any benefit of a learning effect.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ISWT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Myocardial Infraction in the past 6 months
* Able to walk on a treadmill
* Aged ≥ 18

Exclusion Criteria

• Injury or condition that impedes normal gait
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospitals of North Midlands NHS Trust

OTHER

Sponsor Role collaborator

Keele University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Buckley, PhD

Role: STUDY_CHAIR

Keele University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sam Jones, MSc

Role: CONTACT

+44 07841390625

Dean Burt, PhD

Role: CONTACT

+44 07967 581009

Related Links

Access external resources that provide additional context or updates about the study.

https://www.ecss.mobi/DATA/CONGRESSES/GLASGOW_2024/DOCUMENTS/2024_BOA_Web.pdf

Page 220 details a conference abstract from the European Congress for Sports Science at which an initial study on healthy participants was presented

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RG-0393-24

Identifier Type: OTHER

Identifier Source: secondary_id

KeeleU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute Effects of HIIT vs. MICT on HRV
NCT06437145 RECRUITING NA